Zobrazeno 1 - 10
of 884
pro vyhledávání: '"Josep Rodés"'
Autor:
Helena Lopez‐Martinez, Victoria Vilalta, Julio Farjat‐Pasos, Elena Ferrer‐Sistach, Siamak Mohammadi, Claudia Escabia, Dimitri Kalavrouziotis, Helena Resta, Andrea Borrellas, Eric Dumont, Xavier Carrillo, Jean‐Michel Paradis, Eduard Fernández‐Nofrerías, Victoria Delgado, Josep Rodés‐Cabau, Antoni Bayes‐Genis
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2531-2541 (2024)
Abstract Aims In low‐risk patients with severe aortic stenosis (AS), sutureless surgical aortic valve replacement (SU‐SAVR) may be an alternative to transcatheter aortic valve implantation (TAVI). The risk of heart failure hospitalization (HFH) a
Externí odkaz:
https://doaj.org/article/3c753d7731464c41b146d597fdf1d121
Autor:
Michael Pfeiffer, John Boehmer, John Gorcsan, Shunsuke Eguchi, Yoshiyuki Orihara, Michal Laufer Perl, Neal Eigler, William T. Abraham, Julio Nuñez Villota, Elizabeth Lee, Antoni Bayés‐Genís, Gil Moravsky, Saibal Kar, Michael R. Zile, Richard Holcomb, Stefan D. Anker, Gregg W. Stone, Josep Rodés‐Cabau, JoAnn Lindenfeld, Jeroen J. Bax
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2499-2509 (2024)
Abstract Aims Interatrial shunts are under evaluation as a treatment for heart failure (HF); however, their in vivo flow performance has not been quantitatively studied. We aimed to investigate the fluid dynamics properties of the 0.51 cm orifice dia
Externí odkaz:
https://doaj.org/article/6422d42a82654ee9a74441c13147c265
Autor:
Julio I. Farjat-Pasos, Angel Chamorro, Sylvain Lanthier, Mathieu Robichaud, Siddhartha Mengi, Christine Houde, Josep Rodés-Cabau
Publikováno v:
Journal of Stroke, Vol 25, Iss 3, Pp 338-349 (2023)
Patent foramen ovale (PFO) closure, along with medical therapy, has emerged as the therapeutic gold standard in younger (60 years) patients with a PFO-related cerebrovascular event, a complex group of patients who were mostly excluded from PFO closur
Externí odkaz:
https://doaj.org/article/d53a6af968d34eb9aecfa87749c9fee9
Autor:
Mauricio Felippi de Sá Marchi, Pedro Calomeni, Mateus de Miranda Gauza, Gabriel Kanhouche, Lis Victória Ravani, Caio Vinicius Fernandes Rodrigues, Flávio Tarasoutchi, Fábio Sandoli de Brito, Josep Rodés-Cabau, Nicolas M. Van Mieghem, Alexandre Abizaid, Henrique Barbosa Ribeiro
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPeriprocedural myocardial injury (PPMI) frequently occurs after transcatheter aortic valve implantation (TAVI), although its impact on long-term mortality is uncertain.MethodsWe performed a pooled analysis of Kaplan-Meier-derived individual
Externí odkaz:
https://doaj.org/article/7dd3be38358b435caccafdb596fdd6f3
Autor:
Julio I. Farjat‐Pasos, Paul Guedeney, Christine Houde, Alberto Alperi, Mathieu Robichaud, Mélanie Côté, Gilles Montalescot, Josep Rodés‐Cabau
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 19 (2023)
Background Scarce data exist on sex differences in patients with cryptogenic cerebrovascular events undergoing patent foramen ovale (PFO) closure. This study aimed to determine the sex differences in clinical profile, procedural characteristics, and
Externí odkaz:
https://doaj.org/article/67c1e845ef1f49879d21601a535f86ed
Autor:
Berenice Caneiro-Queija, Rodrigo Estévez-Loureiro, Sergio Raposeiras-Roubín, Emad Abu-Assi, Rocío González-Ferreiro, Ignacio Cruz-González, Alejandro Diego-Nieto, Antonio A. de Miguel-Castro, Guillermo Bastos-Fernández, José Antonio Baz-Alonso, Guilles O'Hara, Josep Rodés-Cabau, Andrés Íñiguez-Romo
Publikováno v:
REC: Interventional Cardiology, Vol 4, Iss 4, Pp 304-310 (2022)
RESUMEN Introducción y objetivos: Existe poca información comparativa entre el cierre de la orejuela izquierda (COI) y los anticoagulantes orales de acción directa (ACOD). Nuestro objetivo fue comparar los resultados clínicos entre el COI y los A
Externí odkaz:
https://doaj.org/article/9d657abcba384a388035922225537a8f
Autor:
Berenice Caneiro-Queija, Rodrigo Estévez-Loureiro, Sergio Raposeiras-Roubín, Emad Abu-Assi, Rocío González-Ferreiro, Ignacio Cruz-González, Alejandro Diego-Nieto, Antonio A. de Miguel-Castro, Guillermo Bastos-Fernández, José Antonio Baz-Alonso, Guilles O'Hara, Josep Rodés-Cabau, Andrés Íñiguez-Romo
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 4, Iss 4, Pp 304-310 (2022)
ABSTRACT Introduction and objectives: Information comparing left atrial appendage closure (LAAC) to direct oral anticoagulation (DOAC) therapy is scarce. Our aim is to compare the clinical outcomes between LAAC and DOACs on an elderly population (> 8
Externí odkaz:
https://doaj.org/article/df86cf3537dc40c2a571479a7a6dd375
Autor:
Julio I. Farjat-Pasos, Jorge Nuche, Jules Mesnier, Vassili Panagides, Stephanie Cloutier, Christine Houde, Josep Rodés-Cabau
Publikováno v:
Journal of Stroke, Vol 24, Iss 3, Pp 335-344 (2022)
Transcatheter patent foramen ovale (PFO) closure is a safe and effective treatment for secondary prevention after a PFO-associated stroke as demonstrated in multiple large randomized clinical trials. However, these trials excluded a significant propo
Externí odkaz:
https://doaj.org/article/16f9a914492844eea048960f55494a5a
Autor:
Iria Silva, MD, Pierre Yves Turgeon, MD, Jean-Michel Paradis, MD, Jonathan Beaudoin, MD, Kim O’Connor, MD, Julien Ternacle, MD, PhD, Alberto Alperi, MD, Vassili Panagides, MD, Jules Mesnier, MD, Caroline Gravel, RN, Marie-Annick Clavel, DVM, PhD, François Dagenais, MD, Eric Dumont, MD, Siamak Mohammadi, MD, Philippe Pibarot, DVM, PhD, Mathieu Bernier, MD, Josep Rodés-Cabau, MD, Erwan Salaun, MD, PhD
Publikováno v:
Structural Heart, Vol 7, Iss 2, Pp 100114- (2023)
The use of transcatheter edge-to-edge mitral valve repair (TEER) in symptomatic patients with severe mitral regurgitation (MR) has dramatically increased over the last few years. Current guidelines consider TEER as a reasonable option in symptomatic
Externí odkaz:
https://doaj.org/article/5c88b929604f467e99fd0ffbd8ac8cd6
Autor:
Sébastien Hecht, MSc, Anne-Sophie Zenses, PhD, Jérémy Bernard, MSc, Lionel Tastet, MSc, Nancy Côté, PhD, Leonardo de Freitas Campos Guimarães, MD, Jean-Michel Paradis, MD, Jonathan Beaudoin, MD, Kim O’Connor, MD, Mathieu Bernier, MD, Eric Dumont, MD, Dimitri Kalavrouziotis, MD, Robert Delarochellière, MD, Siamak Mohammadi, MD, Marie-Annick Clavel, DVM, PhD, Josep Rodés-Cabau, MD, Erwan Salaun, MD, PhD, Philippe Pibarot, DVM, PhD
Publikováno v:
Structural Heart, Vol 6, Iss 6, Pp 100106- (2022)
Background: Transcatheter valve-in-valve replacement (ViV-TAVR) has emerged as an alternative to redo-surgical aortic valve replacement (Redo-SAVR) for the treatment of failed surgical aortic bioprostheses. However, the benefit of ViV-TAVR compared w
Externí odkaz:
https://doaj.org/article/a39b6455a1fe4998a127f0576ccd08a0